Tokyo, Japan

Daisuke Hosokawa

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Hitachi Channel Solutions, Corp.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daisuke Hosokawa. Retrieved from https://idiyas.com/inventor/daisuke-hosokawa-siddxhcg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Daisuke Hosokawa: Drug Inspection Innovation

Introduction

Daisuke Hosokawa is an inventor based in Tokyo, Japan, associated with Hitachi Channel Solutions, Corp. His work includes a patented approach to inspecting dispensed drugs using photographed images and drug master data.

Latest Patents

Hosokawa is listed as an inventor on 1 patent: “Drug Inspection Apparatus and Drug Inspection Method.” The invention compares a photographed image of each drug with master data for a dispensed drug group. It classifies inspection outcomes as normal, uncertain, or requiring confirmation. The apparatus also organizes images for review, displaying drugs that need confirmation separately from those whose identity remains uncertain.

Career Highlights

Hosokawa’s patent focuses on supporting drug inspection by combining image comparison with clear categories for inspection results. This approach can help direct human attention to images that warrant additional review.

Collaborations

The patent lists Riichi Katou and Makoto Katsuchi among Hosokawa’s coworkers.

Conclusion

Daisuke Hosokawa’s patented drug inspection apparatus and method apply image-based comparison and review categories to the inspection of dispensed drugs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…